Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-02-18 @ 9:46 AM
Study NCT ID:
NCT01827267
Status:
COMPLETED
Last Update Posted:
2018-07-03
First Post:
2013-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer
Sponsor:
Puma Biotechnology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-01
First Submit QC Date:
None
Study First Post Date:
2013-04-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-08
Results First Submit QC Date:
None
Results First Post Date:
2017-09-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-03-30
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-05-31
Last Update Post Date:
2018-07-03
Last Update Post Date Type:
ACTUAL